These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prostate-specific antigen (PSA) as a surrogate end point for survival in prostate cancer clinical trials. Collette L Eur Urol; 2008 Jan; 53(1):6-9. PubMed ID: 17764823 [No Abstract] [Full Text] [Related]
5. Cryotherapy for prostate cancer: what we know, what we need to know. Theodorescu D J Urol; 2008 Aug; 180(2):437-8. PubMed ID: 18550127 [No Abstract] [Full Text] [Related]
6. Criteria for evaluating patient responses to treatment modalities for prostatic cancer. Slack NH; Murphy GP Urol Clin North Am; 1984 May; 11(2):337-42. PubMed ID: 6375069 [TBL] [Abstract][Full Text] [Related]
8. Controversy over prostate-specific antigen screening has shifted from mortality to overtreatment issues. Ito K Int J Urol; 2009 Sep; 16(9):711-12. PubMed ID: 19777638 [No Abstract] [Full Text] [Related]
9. Prostate cancer gene therapy: outcome of basic research and clinical trials. Nasu Y; Djavan B; Marberger M; Kumon H Tech Urol; 1999 Dec; 5(4):185-90. PubMed ID: 10591255 [TBL] [Abstract][Full Text] [Related]
10. The application of response criteria on reporting treatment results in cancer trials. Kurth K Prog Clin Biol Res; 1990; 359():49-64; discussion 73-4. PubMed ID: 2284297 [No Abstract] [Full Text] [Related]
11. Treatment of early stage prostate cancer: conservative management--delayed therapy. Chodak GW Important Adv Oncol; 1994; ():241-4. PubMed ID: 8206492 [No Abstract] [Full Text] [Related]
12. Clinical trials for prostate cancer. Harv Mens Health Watch; 2002 Mar; 6(8):5-8. PubMed ID: 11916650 [No Abstract] [Full Text] [Related]
13. Size of phase III cancer clinical trials. Simon R Cancer Treat Rep; 1985 Oct; 69(10):1087-93. PubMed ID: 4042088 [No Abstract] [Full Text] [Related]
14. [Practical limitations of a controlled multicenter therapeutic study with the example of advanced inoperable prostatic cancer]. Nagel R Verh Dtsch Ges Inn Med; 1980; 86():1304-16. PubMed ID: 7013324 [No Abstract] [Full Text] [Related]
16. What will the emperor say? Screening for prostate cancer as of 2008. Concato J Cancer J; 2009; 15(1):7-12. PubMed ID: 19197166 [TBL] [Abstract][Full Text] [Related]
18. Early diagnosis of prostate cancer: the continuing debate on the impact on mortality. Höltl W; Lunglmayr G Wien Klin Wochenschr; 2005 Jul; 117(13-14):440-1. PubMed ID: 16091868 [No Abstract] [Full Text] [Related]
19. Prostate cancer and prostate-specific antigen (PSA) screening in Austria. Vutuc C; Schernhammer ES; Haidinger G; Waldhör T Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872 [TBL] [Abstract][Full Text] [Related]
20. Clinical trials referral resource. Current NCI-sponsored clinical trials in prostate cancer: prevention, treatment, supportive care, and imaging. Martin A; Lieberman R; Parnes H; Schoenfeldt M Oncology (Williston Park); 2003 Aug; 17(8):1097-8, 1103-5, 1110-6. PubMed ID: 12966678 [No Abstract] [Full Text] [Related] [Next] [New Search]